How Bayer Lost Its Monopoly: The Story Behind India’s First Compulsory License

Ip Licensing

The legal dispute between Bayer Corporation and the Union of India, along with other parties, centered on India’s first compulsory license for the anticancer drug Sorafenib (marketed as Nexavar). The Intellectual Property Appellate Board (IPAB) thus upheld the license and concluded Bayer had failed to ensure public access to the drug at an affordable price. […]

Compulsory Licencing

Compulsory Licensing

Introduction Compulsory licence is a licence issued by the government to an applicant for making, using, selling a patented product or making use of a patented process without consent of the patentee. Provisions related to compulsory licensing are outlined in Chapter 16 of the Patents Act, 1970. Application of compulsory licencing Section 84 of the […]